MedicinePharmacotherapyPsychiatryBehavioral MedicineClinical PharmacologyPsychopharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyMental IllnessPsychotic DisordersTreatment Of Mental DisordersAntipsychotic EfficacyAntipsychotic Medication UseAt-risk Mental StateMedication Adverse EffectsPsychosis PharmacotherapyPsychosis Risk Syndromes
INTRODUCTION: There are now many existing studies which assess the treatments available for 'at risk mental states', as patients who are believed to be in the prodromal phase of psychotic illness are referred to. However, concerns regarding side effects of possible treatments remain. We here conduct a meta-analysis of the studies available up to July 2016. The aim of this study is to decide what would be the best treatment for 'at high risk patients'. RESULTS: 18 studies were selected for inclusion; 12 showed significance, 5 did not and one tended towards significance. Both antipsychotic medication and psychological intervention show mixed results with cognitive behavioral therapy and olanzapine/amisulpride coming out on top. Omega 3 poly-unsaturated acid also shows promising and consistent results. DISCUSSION: Treatments appear promising but a balance needs to be kept between adverse events and effectiveness of preventing psychosis. CONCLUSION: It is necessary to search further for treatments in order to identify effective treatments with fewer adverse side-effects in this phase of psychotic illness.
93
Epigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility
Matthew D. Anway, Andrea S. Cupp, Mehmet Uzumcu et al. · Science · 2005 · 2.6K citations · Full text
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Kimberly S. Schluns, William C. Kieper, Stephen C. Jameson et al. · Nature Immunology · 2000 · 1.6K citations
Sex differences in autoimmune disease
Caroline C. Whitacre · Nature Immunology · 2001 · 1.3K citations